News | Neuro Imaging | November 22, 2016

Philips to Unveil Suite of Advanced MR-based Software Applications for Assessment of Neurological Disorders at RSNA 2016

neurological disorders, MRI

Philips announced the introduction of a suite of magnetic resonance (MR)-based software applications dedicated to neurology, which will debut at the Radiological Society of North America's (RSNA) 102nd Scientific Meeting and Annual Assembly in Chicago. With these introductions for its Ingenia family of digital MRI systems, Philips is reinforcing its global leadership in Neuro MR software applications, providing radiologists with the necessary tools to resolve complex health questions and explore new territories in neurology.

More than one billion people worldwide are affected by neurological disorders, which most commonly include Alzheimer's, dementia, stroke, traumatic brain injury and multiple sclerosis. According to the World Health Organization, neurological disorders are the leading global burden of disease (economic and health impact), and as an aging population grows, the identification and treatment of these disorders becomes a critical priority in population health management.  

Advanced diagnostics are a critical part of the treatment protocol for neurological disorders. With its superb 3-D imaging of soft tissue, magnetic resonance imaging (MRI) can produce a wealth of structural and physiological information of the brain. It has therefore become a standard in neuroimaging, with 65 percent of neurologists leveraging MR technology over alternative methods. However, 70 percent of physicians often face challenges with their existing neuro-diagnostic tools, which lack effective imaging and visualization techniques. Philips' new suite of neuro-diagnostic applications provides physicians with a comprehensive portfolio of tools designed with the patient in mind, delivering visibility into neurological anatomies and multi-dimensional data to enable diagnostic decision support.

"In a society where neurological disorders impact a large population, continued innovation is critical in improving diagnostic clarity and treatment guidance for all neurological patients," said Eric Jean, general manager of MRI at Philips. "We need to advance a field that has an abundant amount of health information yet to be discovered. Our new suite of decision support solutions will empower radiologists with actionable insights to make fast diagnoses to help improve the patient experience and health outcomes overall, while at the same time reducing cost."

The suite of neuro-diagnostic applications will be available on Philips' Ingenia family of MRI systems, utilizing Philips' dStream digital broadband architecture technology to provide high quality images at remarkable speed.  Unique features include:

Black Blood Imaging – Boosts diagnostic confidence for radiologists by providing a high resolution 3-D brain image with reduction of the blood signal [4], resulting in higher image quality and giving radiologists deeper insights.

4-D-Trance – Provides contrast-free dynamic (4-D) imaging of the brain vascular anatomy. 4-D Trance is a non-contrast technique promoting patient comfort and enabling radiologists to evaluate both the vascular anatomy and blood flow dynamics.

MultiBand Sense – Allows simultaneous acquisition of multiple slices in the brain in fMRI exams, enabling accelerated neurofunctional scans at high speed and high resolution. This feature provides radiologists the option to increase coverage or resolution without increasing scan time.

The suite of neuro-diagnostic applications will also be seamlessly integrated into the latest version of the Philips IntelliSpace Portal, also planned to make its debut at the RSNA annual meeting in Chicago. With the IntelliSpace Portal, radiologists have access to the latest clinical capabilities covering their advanced visual analysis needs on a single platform to provide a comprehensive overview of the patient for quick detection, confident diagnosis and efficient follow-up. This newest version of Philips IntelliSpace Portal places greater focus on enhanced depth of clinical analysis in neurology, for even the most complex patients.

For more information: www.usa.philips.com/healthcare

Related Content

Delta T1 Maps Provide Quantitative, Automated Solution to Assess Brain Tumor Burden
News | Neuro Imaging | July 05, 2019
Imaging Biometrics LLC (IB) a subsidiary of IQ-AI Ltd., is highlighting a recently published study in the American...
TeraRecon Unveils iNtuition AI Data Extractor
News | Advanced Visualization | July 03, 2019
Artificial Intelligence (AI) and advanced visualization company TeraRecon announced its new iNtuition AI Data Extractor...
A 3-D printed model (left) and a model constructed in augmented reality (right), both of a kidney with a tumor. In both models, the kidney is clear; the tumor is visible in purple on the AR model and in white on the 3-D printed model.

A 3-D printed model (left) and a model constructed in augmented reality (right), both of a kidney with a tumor. In both models, the kidney is clear; the tumor is visible in purple on the AR model and in white on the 3-D printed model. Photo courtesy of Nicole Wake, Ph.D.

Feature | Advanced Visualization | July 02, 2019 | By Jeff Zagoudis
Three-dimensional (3-D) printing and...

Image courtesy of Philips Healthcare

Feature | Molecular Imaging | July 01, 2019 | By Sharvari Rale
Diagnostic procedures have always been a cornerstone of early prognosis and patient triaging.
TeraRecon Receives FDA Clearance for Northstar AI Results Explorer
Technology | Artificial Intelligence | June 20, 2019
Advanced visualization and artificial intelligence (AI) technology provider TeraRecon has successfully completed a U.S...
Third FDA Clearance Announced for Zebra-Med's AI Solution for Brain Bleed Alerts
Technology | Artificial Intelligence | June 19, 2019
Zebra Medical Vision announced it has received its third U.S. Food and Drug Administration (FDA) 510(k) clearance for...
SyMRI Software Receives FDA Clearance for Use With Siemens MRI Systems
Technology | Magnetic Resonance Imaging (MRI) | June 14, 2019
SyntheticMR announced U.S. Food and Drug Administration (FDA) clearance for clinical use of its SyMRI Image and SyMRI...
Materialise Receives FDA Clearance for Cardiovascular Planning Software Suite
Technology | Advanced Visualization | June 13, 2019
Three-dimensional (3-D) printing software and solutions company Materialise has received U.S. Food and Drug...
Medivis SurgicalAR Gets FDA Clearance
Technology | Virtual and Augmented Reality | June 10, 2019
Medivis announced that its augmented reality (AR) technology platform for surgical applications, SurgicalAR, has...
Ann Arbor Startup Launches Augmented Reality MRI Simulator
Technology | Virtual and Augmented Reality | June 04, 2019
SpellBound, an Ann Arbor startup specializing in augmented reality (AR) tools for children in hospitals, has officially...